Don't Revive Opioid Patents, Generics Maker Tells Fed. Circ.
Kashiv Pharma LLC on Monday asked the Federal Circuit for permission to intervene in Grünenthal GmbH's patent infringement litigation over the opioid painkiller Opana ER, arguing the patents should remain invalid even though...To view the full article, register now.
Already a subscriber? Click here to view full article